Es gab 50 kürzliche Insider-Transaktionen für SpringWorks Therapeutics, Inc. (SWTX), darunter 15 Käufe und 35 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $18.8M und die gesamten Insider-Verkäufe auf $16.02M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Lynch Daniel, Fuhrman Alan, Mackay Martin. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — SWTX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-05-14 |
Lynch Daniel |
Director |
RSU-Zuteilung |
10,060 |
- |
- |
93,004 |
| 2025-05-14 |
Fuhrman Alan |
Director |
RSU-Zuteilung |
10,060 |
- |
- |
24,727 |
| 2025-05-14 |
Mackay Martin |
Director |
RSU-Zuteilung |
10,060 |
- |
- |
20,023 |
| 2025-05-14 |
Lewis-hall Freda C |
Director |
RSU-Zuteilung |
10,060 |
- |
- |
24,727 |
| 2025-05-14 |
Alban Carlos |
Director |
RSU-Zuteilung |
10,060 |
- |
- |
28,861 |
| 2025-05-14 |
Hambleton Julie |
Director |
RSU-Zuteilung |
10,060 |
- |
- |
14,155 |
| 2025-03-03 |
Islam Saqib |
Chief Executive Officer |
Informierter Verkauf |
600 |
$56.89 |
$34.13K |
954,869 |
| 2025-03-03 |
Edris Badreddin |
Chief Operating Officer |
Informierter Verkauf |
400 |
$56.20 |
$22.48K |
169,712 |
| 2025-02-27 |
Islam Saqib |
Chief Executive Officer |
RSU-Steuereinbehalt |
30,756 |
$53.41 |
$1.64M |
1,003,869 |
| 2025-02-20 |
Lynch Daniel |
Director |
Informierter Verkauf |
3,582 |
$61.24 |
$219.35K |
82,944 |
| 2025-02-20 |
Islam Saqib |
Chief Executive Officer |
Informierter Verkauf |
5,068 |
$61.24 |
$310.35K |
1,034,625 |
| 2025-02-20 |
Ashar Bhavesh |
Chief Commercial Officer |
Informierter Verkauf |
1,016 |
$61.19 |
$62.17K |
62,053 |
| 2025-02-14 |
Lynch Daniel |
Director |
Informierter Verkauf |
400 |
$60.00 |
$24K |
130,544 |
| 2025-02-14 |
Islam Saqib |
Chief Executive Officer |
Informierter Verkauf |
10,672 |
$59.92 |
$639.49K |
1,063,953 |
| 2025-02-12 |
Islam Saqib |
Chief Executive Officer |
RSU-Steuereinbehalt |
13,186 |
$59.28 |
$781.67K |
1,074,625 |
| 2025-02-10 |
Lynch Daniel |
Director |
Informierter Verkauf |
65,600 |
$55.51 |
$3.64M |
130,944 |
| 2025-02-10 |
Islam Saqib |
Chief Executive Officer |
Informierter Verkauf |
48,000 |
$53.30 |
$2.56M |
1,002,502 |
| 2025-02-10 |
Hambleton Julie |
Director |
Optionsausübung (Verkauf) |
13,774 |
$32.27 |
$444.49K |
- |
| 2025-02-10 |
Edris Badreddin |
Chief Operating Officer |
Informierter Verkauf |
30,000 |
$53.13 |
$1.59M |
189,712 |
| 2025-02-10 |
Pichl Daniel |
Chief People Officer |
Optionsausübung (Verkauf) |
13,750 |
$27.64 |
$380.05K |
31,250 |
| 2025-01-10 |
Perier Francis I Jr |
Chief Financial Officer |
RSU-Zuteilung |
34,419 |
$43.00 |
$1.48M |
34,419 |
| 2025-01-10 |
Weinstein Herschel S |
General Counsel & Secretary |
RSU-Zuteilung |
35,431 |
$43.00 |
$1.52M |
35,431 |
| 2025-01-10 |
Islam Saqib |
Chief Executive Officer |
RSU-Zuteilung |
109,329 |
$43.00 |
$4.7M |
109,329 |
| 2025-01-10 |
Nofi Michael |
Chief Accounting Officer |
RSU-Zuteilung |
20,246 |
$43.00 |
$870.58K |
20,246 |
| 2025-01-10 |
Edris Badreddin |
Chief Operating Officer |
RSU-Zuteilung |
78,960 |
$43.00 |
$3.4M |
78,960 |
| 2025-01-10 |
Pichl Daniel |
Chief People Officer |
RSU-Zuteilung |
37,455 |
$43.00 |
$1.61M |
37,455 |
| 2025-01-10 |
Ashar Bhavesh |
Chief Commercial Officer |
RSU-Zuteilung |
50,615 |
$43.00 |
$2.18M |
50,615 |
| 2025-01-10 |
Cassidy James |
Chief Medical Officer |
RSU-Zuteilung |
50,615 |
$43.00 |
$2.18M |
50,615 |
| 2025-01-10 |
Lin Tai-an |
Chief Scientific Officer |
RSU-Zuteilung |
20,246 |
$43.00 |
$870.58K |
20,246 |
| 2025-01-06 |
Perier Francis I Jr |
Chief Financial Officer |
RSU-Steuereinbehalt |
3,283 |
$38.86 |
$127.58K |
49,110 |
| 2025-01-06 |
Weinstein Herschel S |
General Counsel & Secretary |
RSU-Steuereinbehalt |
2,279 |
$38.86 |
$88.56K |
43,113 |
| 2025-01-06 |
Islam Saqib |
Chief Executive Officer |
RSU-Steuereinbehalt |
12,359 |
$38.86 |
$480.27K |
975,668 |
| 2025-01-06 |
Nofi Michael |
Chief Accounting Officer |
RSU-Steuereinbehalt |
1,009 |
$38.86 |
$39.21K |
23,694 |
| 2025-01-06 |
Edris Badreddin |
Chief Operating Officer |
RSU-Steuereinbehalt |
4,416 |
$38.86 |
$171.61K |
192,689 |
| 2025-01-06 |
Pichl Daniel |
Chief People Officer |
RSU-Steuereinbehalt |
1,759 |
$38.86 |
$68.35K |
37,943 |
| 2025-01-06 |
Ashar Bhavesh |
Chief Commercial Officer |
RSU-Steuereinbehalt |
2,284 |
$38.86 |
$88.76K |
45,746 |
| 2025-01-06 |
Cassidy James |
Chief Medical Officer |
RSU-Steuereinbehalt |
1,658 |
$38.86 |
$64.43K |
64,408 |
| 2025-01-05 |
Perier Francis I Jr |
Chief Financial Officer |
RSU-Steuereinbehalt |
3,278 |
$38.19 |
$125.19K |
52,393 |
| 2025-01-05 |
Weinstein Herschel S |
General Counsel & Secretary |
RSU-Steuereinbehalt |
3,272 |
$38.19 |
$124.96K |
45,392 |
| 2025-01-05 |
Islam Saqib |
Chief Executive Officer |
RSU-Steuereinbehalt |
12,872 |
$38.19 |
$491.58K |
988,027 |
| 2025-01-05 |
Nofi Michael |
Chief Accounting Officer |
RSU-Steuereinbehalt |
1,636 |
$38.19 |
$62.48K |
24,703 |
| 2025-01-05 |
Edris Badreddin |
Chief Operating Officer |
RSU-Steuereinbehalt |
5,561 |
$38.19 |
$212.37K |
197,105 |
| 2025-01-05 |
Pichl Daniel |
Chief People Officer |
RSU-Steuereinbehalt |
2,522 |
$38.19 |
$96.32K |
39,702 |
| 2025-01-05 |
Ashar Bhavesh |
Chief Commercial Officer |
RSU-Steuereinbehalt |
3,825 |
$38.19 |
$146.08K |
48,030 |
| 2025-01-05 |
Cassidy James |
Chief Medical Officer |
RSU-Steuereinbehalt |
3,465 |
$38.19 |
$132.33K |
66,066 |
| 2025-01-04 |
Perier Francis I Jr |
Chief Financial Officer |
RSU-Steuereinbehalt |
3,582 |
$38.19 |
$136.8K |
55,671 |
| 2025-01-04 |
Weinstein Herschel S |
General Counsel & Secretary |
RSU-Steuereinbehalt |
3,575 |
$38.19 |
$136.53K |
48,664 |
| 2025-01-04 |
Islam Saqib |
Chief Executive Officer |
RSU-Steuereinbehalt |
13,469 |
$38.19 |
$514.38K |
1,000,899 |
| 2025-01-04 |
Nofi Michael |
Chief Accounting Officer |
RSU-Steuereinbehalt |
2,388 |
$38.19 |
$91.2K |
26,339 |
| 2025-01-04 |
Edris Badreddin |
Chief Operating Officer |
RSU-Steuereinbehalt |
6,934 |
$38.19 |
$264.81K |
202,666 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall